PDCD1 and melanoma: Interestingly, the TOX expression level in the TI T cells was inversely correlated with the anti-PD-1 immunotherapy response in two published cohorts of patients with cancer, i.e., melanoma cohorts [19] (Fig. 5e) and NSCLC cohorts [21] (Fig. 5f).